Advertisement
Advertisement
INTS
Intensity Therapeutics, Inc. Common stock
3.94
USDSponsored
+0.02
+0.38%
Jun 22, 15:59 UTC -4
Closed
Pre-Market
3.95
+0.02
+0.41%
INTS Earnings Reports
Positive Surprise Ratio
INTS beat 7 of 12 last estimates.
58%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Intensity Therapeutics, Inc. Common stock earnings per share and revenue
On May 07, 2026, INTS reported earnings of -0.96 USD per share (EPS) for Q1 26, beating the estimate of -1.10 USD, resulting in a 13.26% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.39% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
FAQ
What were Intensity Therapeutics, Inc. Common stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Intensity Therapeutics, Inc. Common stock reported EPS of -$0.96, beating estimates by 13.26%, and revenue of $0.00, 0% as expectations.
How did the market react to Intensity Therapeutics, Inc. Common stock's Q1 2026 earnings?
The stock price moved down -0.39%, changed from $5.11 before the earnings release to $5.09 the day after.
When is Intensity Therapeutics, Inc. Common stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Intensity Therapeutics, Inc. Common stock's next earnings report?
Based on --
analysts, Intensity Therapeutics, Inc. Common stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement